THE CIGNA GROUP

Explore Cigna’s July 2026 Form 3 filings—direct shares, options, phantom stock—revealing a balanced executive‑ownership strategy that boosts investor confidence and preserves capital in a competitive health‑insurance market.

Discover how Cigna’s July 2026 Form 3 filings reveal executive equity strategies, dilution risks, and ESG opportunities—insights every investor needs.

Brokerages boost earnings with tech‑focused investments, turning early‑stage stakes and follow‑on gains into a new revenue driver.

Explore The Cigna Group’s 2025‑26 Annual Report: how the firm is boosting recurring revenue, expanding in India’s Tier‑II/III markets and the GCC, and leveraging a digital, distribution‑led wealth‑management model for sustainable growth.

Discover how Cigna Group’s 2025 results show resilience, with palm oil price gains and a cashew turnaround, driving future growth and shareholder value.

Discover how Cigna Group’s 30th AGM will transform shareholder engagement with secure video‑conference voting, real‑time transparency, and easy access to FY‑2026 reports.

Discover how Cigna’s $3 million youth mental‑health grant and BGCA’s trauma‑informed toolkit are boosting access, reducing distress, and driving future care innovations.

Discover how Cigna Group’s steady, value‑based strategy keeps it resilient in today’s shifting healthcare market.

CI GAM’s $3.2 bn Invesco acquisition boosts its AUM and fee‑income, while Tiger Brands cuts costs and expands margins—showing how asset‑transfer and operational reforms drive financial gains.